Catalyst Wire Dossier Catalyst Wire Dossier

BYOOVIZ

ranibizumab-nuna · Biogen Inc.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for BYOOVIZ, covering 2021-09-17 to 2026-03-30. Get the full timeline:

Most recent: FDA Approved: BYOOVIZ — Supplemental Application (BIOGEN INC.)

See pricing